Asako Takanohashi

Asako Takanohashi

Auto-generated profile, based on publicly available information

Asako Takanohashi

Children’s Hospital of Philadelphia 2 Division of Neurology, Department of Pediatrics Philadelphia, PA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
GBGeneviève Bernard
Geneviève Bernard
ECEliane Chouery
Eliane Chouery
MPMaria Lisa Putorti
Maria Lisa Putorti
MTMartine Tétreault
Martine Tétreault
ATAsako Takanohashi
Asako Takanohashi
BBBernard Brais
Bernard Brais

1 May 2013 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CSCas Simons
Cas Simons
NWNicole Wolf
Nicole Wolf
NMNathan McNeil
Nathan McNeil
LCLjubica Caldovic
Ljubica Caldovic
JDJoseph M. Devaney
Joseph M. Devaney
AVAdeline Vanderver
Adeline Vanderver

9 May 2016 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
AVAdeline Vanderver
Adeline Vanderver
CSCas Simons
Cas Simons
GHGuy Helman
Guy Helman
JCJoanna Crawford
Joanna Crawford
NWNicole Wolf
Nicole Wolf
RTRyan J. Taft
Ryan J. Taft

1 May 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
LGLong Guo
Long Guo
DBDébora Romeo Bertola
Débora Romeo Bertola
ATAsako Takanohashi
Asako Takanohashi
ASAsuka Saito
Asuka Saito
YSYuko Segawa
Yuko Segawa
SIShiro Ikegawa
Shiro Ikegawa

1 January 2006 in Mental Retardation and Developmental Disabilities Research Reviews
Verified
Journal Article
Closed access
PDF file
LCLi‐Jin Chew
Li‐Jin Chew
ATAsako Takanohashi
Asako Takanohashi
MBMichael Bell
Michael Bell

29 August 2017 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
JCJulian Curiel
Julian Curiel
GBGuillermo Rodríguez Bey
Guillermo Rodríguez Bey
ATAsako Takanohashi
Asako Takanohashi
MBMarianna Bugiani
Marianna Bugiani
XFXiaoqin Fu
Xiaoqin Fu
AVAdeline Vanderver
Adeline Vanderver
Hypomyelinating leukodystrophies are heritable disorders defined by lack of development of brain myelin, but the cellular mechanisms of hypomyelination are often poorly understood. Mutations in TUBB4A, encoding the tubulin isoform tubulin beta class IVA (Tubb4a), result in the symptom complex of hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC). Additionally, TUBB4A mutations are known to result in a broad phenotypic spectrum, ranging from primary dystonia (DYT4), isolated hypomyelination with spastic quadriplegia, and an infantile onset encephalopathy, suggesting multiple cell types may be involved. We present a study of the cellular effects of TUBB4A mutations responsible for H-ABC (p.Asp249Asn), DYT4 (p.Arg2Gly), a severe combined phenotype with hypomyelination and encephalopathy (p.Asn414Lys), as well as milder phenotypes causing isolated hypomyelination (p.Val255Ile and p.Arg282Pro). We used a combination of histopathological, biochemical and cellular approaches to determine how these different mutations may have variable cellular effects in neurons and/or oligodendrocytes. Our results demonstrate that specific mutations lead to either purely neuronal, combined neuronal and oligodendrocytic or purely oligodendrocytic defects that closely match their respective clinical phenotypes. Thus, the DYT4 mutation that leads to phenotypes attributable to neuronal dysfunction results in altered neuronal morphology, but with unchanged tubulin quantity and polymerization, with normal oligodendrocyte morphology and myelin gene expression. Conversely, mutations associated with isolated hypomyelination (p.Val255Ile and p.Arg282Pro) and the severe combined phenotype (p.Asn414Lys) resulted in normal neuronal morphology but were associated with altered oligodendrocyte morphology, myelin gene expression, and microtubule dysfunction. The H-ABC mutation (p.Asp249Asn) that exhibits a combined neuronal and myelin phenotype had overlapping cellular defects involving both neuronal and oligodendrocyte cell types in vitro. Only mutations causing hypomyelination phenotypes showed altered microtubule dynamics and acted through a dominant toxic gain of function mechanism. The DYT4 mutation had no impact on microtubule dynamics suggesting a distinct mechanism of action. In summary, the different clinical phenotypes associated with TUBB4A reflect the selective and specific cellular effects of the causative mutations. Cellular specificity of disease pathogenesis is relevant to developing targeted treatments for this disabling condition.